Menlo Therapeutics
Why Robinhood?
You can watch MNLO and buy or sell other stocks, ETFs, and their options commission-free!About MNLO
Menlo Therapeutics is a clinical late-stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus (itch) associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. We are concurrently evaluating the use of serlopitant for refractory chronic cough, a cough that persists for greater than eight weeks despite treatment of any identified underlying cause.
MNLO Key Statistics
Stock Snapshot
The current Menlo Therapeutics(MNLO) stock price is $3.50, with a market capitalization of 116.63M. The stock trades at a price-to-earnings (P/E) ratio of -1.03.
On 2026-05-08, Menlo Therapeutics(MNLO) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 283.24K.
The stock's 52-week range extends from a low of $0.28 to a high of $1.96.
The stock's 52-week range extends from a low of $0.28 to a high of $1.96.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.